RecruitingPhase 1NCT07203755

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Studying Diphtheria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CanSino Biologics Inc.
Principal Investigator
Yanxia Wang
Henan Center for Disease Control and Prevention
Intervention
Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Meningococcal Group ACYW135 (Conjugate) Combined Vaccine (DTcP-Hib-MCV4)(biological)
Enrollment
260 enrolled
Eligibility
6 years · All sexes
Timeline
20252029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07203755 on ClinicalTrials.gov

Other trials for Diphtheria

Additional recruiting or active studies for the same condition.

See all trials for Diphtheria

← Back to all trials